Literature DB >> 27750198

Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.

Sunhee Kang1, Young Mi Kim2, Ryang Yeo Kim3, Min Jung Seo2, Zaesung No2, Kiyean Nam4, Sanghee Kim5, Jaeseung Kim6.   

Abstract

The anti-tubercular activity of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl)imidazo [1,2-a]pyridine-3-carboxamide (Q203) is modified by varying its side chain. In this study, we synthesized Q203 analogues with different side chains and studied their effects on anti-tubercular activity. Many analogues showed good potency against M. tuberculosis replicating in liquid broth culture medium (extracellular activity) regardless of chain length and conformational changes. However, a polar character in the side chain region was unfavorable for anti-tubercular activity. The analogues, 25, 28, 35, and 36, displayed excellent activity against M. tuberculosis replicating inside macrophages (intracellular activity) and promising pharmacokinetic (PK) properties with high drug exposure level and long half-life. Copyright Â
© 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Imidazo[1,2-a]pyridine-3-carboxamide (IPA); Pharmacokinetics; Q203; Structure-activity relationship (SAR); Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27750198     DOI: 10.1016/j.ejmech.2016.09.082

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.

Authors:  Garrett C Moraski; Ryan Bristol; Natalie Seeger; Helena I Boshoff; Patricia Siu-Yee Tsang; Marvin J Miller
Journal:  ChemMedChem       Date:  2017-06-27       Impact factor: 3.466

Review 2.  Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review.

Authors:  Mushtaq Ahmad Wani; Devendra Kumar Dhaked
Journal:  Mol Divers       Date:  2021-11-11       Impact factor: 3.364

3.  Dichlorotrifluoromethoxyacetic Acid: Preparation and Reactivity.

Authors:  Riadh Zriba; Alaric Desmarchelier; Frédéric Cadoret; Sébastien Bouvet; Anne-Laure Barthelemy; Bruce Pégot; Patrick Diter; Guillaume Dagousset; Jean-Claude Blazejewski; Elsa Anselmi; Yurii Yagupolskii; Emmanuel Magnier
Journal:  Molecules       Date:  2017-06-09       Impact factor: 4.411

Review 4.  Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.

Authors:  Paweł Kozyra; Monika Pitucha
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

5.  On drug discovery against infectious diseases and academic medicinal chemistry contributions.

Authors:  Yves L Janin
Journal:  Beilstein J Org Chem       Date:  2022-09-29       Impact factor: 2.544

6.  Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.

Authors:  Oluseye K Onajole; Shichun Lun; Young Ju Yun; Damkam Y Langue; Michelle Jaskula-Dybka; Adrian Flores; Eriel Frazier; Ashle C Scurry; Ambernice Zavala; Karen R Arreola; Bryce Pierzchalski; A Jean-Luc Ayitou; William R Bishai
Journal:  Chem Biol Drug Des       Date:  2020-07-09       Impact factor: 2.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.